INHIBITION OR PREVENTION OF DISTURBED ANGIOGENIC REGULATION WITH USING RAPAMYCIN DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING RAPAMYCIN DERIVATIVE

摘要

FIELD: medicine, pharmaceutics.;SUBSTANCE: what is offered is using 40-O-(2-hydroxyethyl)rapamycin for preparing a pharmaceutical composition for treating a renal tumour representing carcinoma.;EFFECT: 40-O-(2-hydroxyethyl)rapamycin twice reduces tumour growth time or death rate of the patients with advanced renal cell carcinoma.;1 tbl